Sensex and Nifty Pare Gains as Investors Book Profits at Eight Month Highs
Indian equity benchmarks pared their intraday gains on November 12 after touching eight-month highs, as investors booked profits at elevated levels. Selling pressure in IT and pharmaceutical stocks limited the market's upside, while NBFC and insurance stocks emerged as key gainers.
By Finblage Editorial Desk
5:05 pm
12 November 2026
Indian equity markets witnessed profit booking at higher levels on November 12, with the benchmark indices giving up a portion of their intraday gains after reaching their highest levels in eight months. The Sensex slipped nearly 250 points from the day's high, while the Nifty 50 fell below the 25,300 mark as investors opted to lock in profits following the recent rally.
The selling pressure reflected cautious investor behaviour at elevated market valuations, particularly after the benchmarks extended their upward momentum and touched multi-month highs. Profit booking in heavyweight stocks contributed to the moderation in market gains.
Sectoral performance remained mixed during the session. Non-Banking Financial Companies (NBFCs) and insurance stocks emerged among the leading gainers, providing some support to the broader market. However, weakness in information technology and pharmaceutical stocks restricted the overall upside in benchmark indices.
The intraday reversal indicated that investors remained selective in their buying approach, with profit booking emerging at higher market levels. Despite the moderation in gains, the benchmarks continued to trade around elevated levels, reflecting the underlying strength of the recent market rally.
Sources & Disclaimer
This article is compiled from publicly available information, including company disclosures, stock exchange filings, regulatory announcements, and reports from global and domestic financial publications. The content has been editorially reviewed and enhanced by the Finblage Editorial Desk for clarity and investor awareness purposes only.
All information provided on Finblage is strictly for educational and informational use and should not be considered as financial, investment, legal, or professional advice. Readers are advised to conduct their own independent research and consult a certified financial advisor before making any investment decisions. Finblage shall not be held responsible for any losses arising from the use of information published on this website.
Premium Edition

Sector > FMCG
Pricing Power on Trial : India's FMCG Majors Reach for the Lever Again in Q2 FY27
India’s FMCG sector is entering another pricing cycle as crude and palm-oil inflation pressures margins. Major players are opting for calibrated price hikes and shrinkflation to protect affordability while recovering costs. Despite these pressures, Q1 FY27 delivered resilient, volume-led growth, indicating healthy underlying demand.
11 August 2026
_edited.png)


